Novonix Gets Listing Rule Waivers for Share Purchase Plan

MT Newswires Live
Jul 06

Novonix (ASX:NVX) said it received waivers from the Australian Securities Exchange to execute a share purchase plan at an issue price of AU$0.16 per share without shareholder approval, according to a Monday filing with the bourse.

The waivers will allow the shares to be excluded from calculating the company's available placement capacity, and its directors will be able to participate in the share purchase plan, per the filing.

The waivers are conditioned on the issue price of the shares being at least AU$0.16 each, and the number of shares to be issued under the plan must not surpass 30% of the company's shares on issue.

Novonix said seeking shareholder approval would have delayed the share purchase plan and prevented it from offering the shares on the same terms as a separate institutional placement.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10